NCT05427149View on ClinicalTrials.gov

The Effect of Intrathecal Magnesium Sulfate on Shivering

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 10, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

August 30, 2022

Conditions
Magnesium Sulfate Causing Adverse Effects in Therapeutic UsePostoperative ShiveringCesarean Section Complications
Interventions
DRUG

25 mg MgSO4 (Magnezyum Sulfat %15, Biofarma, Istanbul, Turkey)

It will be evaluated whether there is postpinal shivering in the cases.

Trial Locations (1)

65080

Van yuzuncu Yıl University, Dursun Odabas Medical Center, Van

All Listed Sponsors
lead

Yuzuncu Yıl University

OTHER